- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 247/00 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups
Patent holdings for IPC class C07D 247/00
Total number of patents in this class: 49
10-year publication summary
0
|
2
|
1
|
6
|
7
|
4
|
1
|
3
|
8
|
5
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Gilead Sciences, Inc. | 1879 |
3 |
BeiGene, Ltd. | 319 |
2 |
Covestro Deutschland AG | 2429 |
2 |
Shanghai Haiyan Pharmaceutical Technology Co. Ltd | 100 |
2 |
Yangtze River Pharmaceutical (Group) Co., Ltd. | 136 |
2 |
Covestro Intellectual Property GmbH & Co. KG | 501 |
2 |
Merck Sharp & Dohme Corp. | 2247 |
1 |
Merck Patent GmbH | 5909 |
1 |
Taiwan Semiconductor Manufacturing Company, Ltd. | 36809 |
1 |
Massachusetts Institute of Technology | 9795 |
1 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
1 |
Board of Regents, The University of Texas System | 5370 |
1 |
Abide Therapeutics, Inc. | 26 |
1 |
Alexium Limited | 3 |
1 |
Duk San Neolux Co., Ltd. | 512 |
1 |
Emory University | 1498 |
1 |
FLX Bio, Inc. | 5 |
1 |
Fundacao Universidade Federal de Sao Carlos - Ufscar | 14 |
1 |
H. Lee Moffitt Cancer Center and Research Institute, Inc. | 829 |
1 |
Kadmon Corporation, LLC | 84 |
1 |
Other owners | 22 |